Search research articles
Contact Us
Filters
Showing results (521-530 of 738) with videos related to
Page
of 74
Sort By:
Kidney International
|
March 23, 2005
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program
Tarek M El-Achkar, Suzanne E Ohmit, Peter A McCullough, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 17, 2009
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES)
Adam Whaley-Connell, James R Sowers, Peter A McCullough, et al.
Diabetes, Obesity & Metabolism
|
October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
You-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Journal of the American Society of Hypertension : JASH
|
November 25, 2014
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013
William B White, J Rick Turner, Domenic A Sica, et al.
Journal of Diabetes and Its Complications
|
March 5, 2005
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial
George L Bakris, David S H Bell, Vivian Fonseca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 23, 2011
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP)
Lesley A Stevens, Suying Li, Manjula Kurella Tamura, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
Diabetes, Obesity & Metabolism
|
September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial
Peter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
The American Journal of Cardiology
|
June 14, 2008
A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure
Gerasimos S Filippatos, Chris Adamopoulos, Xuemei Sui, et al.
Diabetes, Obesity & Metabolism
|
January 9, 2020
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL
Nienke M A Idzerda, Lindsay E Clegg, Adrian F Hernandez, et al.
Page
of 74
Search research articles
Search
Showing results (521-530 of 738) with videos related to
Sort By:
Page
of 74
Kidney International
|
March 23, 2005
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program
Tarek M El-Achkar, Suzanne E Ohmit, Peter A McCullough, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 17, 2009
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES)
Adam Whaley-Connell, James R Sowers, Peter A McCullough, et al.
Diabetes, Obesity & Metabolism
|
October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
You-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Journal of the American Society of Hypertension : JASH
|
November 25, 2014
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013
William B White, J Rick Turner, Domenic A Sica, et al.
Journal of Diabetes and Its Complications
|
March 5, 2005
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial
George L Bakris, David S H Bell, Vivian Fonseca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 23, 2011
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP)
Lesley A Stevens, Suying Li, Manjula Kurella Tamura, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
Diabetes, Obesity & Metabolism
|
September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial
Peter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
The American Journal of Cardiology
|
June 14, 2008
A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure
Gerasimos S Filippatos, Chris Adamopoulos, Xuemei Sui, et al.
Diabetes, Obesity & Metabolism
|
January 9, 2020
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL
Nienke M A Idzerda, Lindsay E Clegg, Adrian F Hernandez, et al.
Page
of 74